Get a prescription for Zepbound online in Canada

Zepbound is a prescription medication containing tirzepatide. In Canada, it is authorized for chronic weight management in eligible adults with obesity, or adults who are overweight and have at least one weight-related health condition, alongside diet and physical activity changes.

Tirzepatide activates both GIP and GLP-1 receptors. These pathways influence appetite, feelings of fullness, and metabolic processes. A healthcare provider can determine whether Zepbound is appropriate based on your health history, current medications, and weight-management goals.

Zepbound works by activating two hormone pathways, GIP and GLP-1, both of which play a role in appetite control and blood sugar regulation. This dual action is what sets tirzepatide medications apart from other weight loss injections on the market.

Zepbound helps with weight loss, not by burning fat directly, but by influencing the brain signals that drive how much you eat. When combined with consistent lifestyle habits like a balanced diet and regular physical activity, Zepbound works best and can enable significant weight loss.

Weight loss with Zepbound varies from person to person. In the SURMOUNT-1 clinical trial, adults without diabetes lost an average of about 15% to 21% of their starting body weight after 72 weeks, depending on the maintenance dose, alongside diet and physical activity changes.

Your results can differ based on your starting weight, dose, how long you use Zepbound, lifestyle habits, and individual response. A healthcare provider can help you set realistic expectations and monitor your progress over time.

Many people starting Zepbound notice changes in appetite and blood sugar improvements within the first few weeks. Weight loss usually happens after 2 to 3 months, particularly after you move to a higher dose, and results can continue over 6 to 12 months of consistent use. 

It’s important to follow your Phoenix provider's guidance on when to take Zepbound and how to adjust your schedule.

Zepbound side effects are most common during dose increases and tend to improve over time as the body adjusts to the tirzepatide. The most frequently reported ones include nausea, vomiting, diarrhea, constipation, and stomach discomfort. Eating smaller meals, chewing slowly, and avoiding greasy or rich foods can help.

Severe or persistent side effects should always be evaluated by a medical professional right away. If you have concerns about the side effects of Zepbound, a licensed healthcare provider is the best resource.

After stopping Zepbound, its effects on appetite and fullness gradually wear off. Some people regain weight after treatment is discontinued, particularly when the lifestyle changes that supported weight loss are difficult to maintain.

If you are considering stopping Zepbound, speak with your healthcare provider. They can help you plan what comes next, review your progress, and discuss strategies for maintaining weight loss or whether another treatment approach is appropriate.

How to inject Zepbound: This treatment comes as a pre-filled Zepbound pen designed for subcutaneous (under-the-skin) injection. Common Zepbound injection sites include the abdomen, thigh, or upper arm. Rotate your injection site each week to reduce irritation.

Zepbound pen instructions: Attach a new needle, prime the pen before first use, dial to your prescribed Zepbound dose, and inject at a 90-degree angle. Full Zepbound injection instructions are included in the package insert.

Zepbound dosing schedule: The standard Zepbound administration schedule is once weekly, on the same day each week. Zepbound strength comes in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses, usually starting with a low dose and increasing gradually.

How to store Zepbound: Zepbound refrigeration is required before first use. Store unopened pens in the refrigerator between 2°C and 8°C (36°F and 46°F). After first use, Zepbound pen storage allows you to keep the pen at room temperature (up to 25°C / 77°F) for up to 56 days. Store Zepbound away from direct heat and sunlight. Never freeze the pen, and always put the cap back on after each use.

Zepbound is a tirzepatide medication that targets both GLP-1 and GIP receptors, while Ozempic is a semaglutide medication that targets GLP-1 only. This difference in the mechanism of action may lead to different weight loss outcomes for different people.

Talk to a licensed healthcare provider about which option makes sense for your health goals.